Aadel Chaudhuri

Aadel Chaudhuri has advanced cell-free DNA epigenomic approaches for MRD detection that complement mutation-based methods by capturing methylation and chromatin accessibility changes characteristic of residual tumor cells. His research integrating cfDNA methylation profiling with fragment analysis has improved MRD sensitivity in tumors with low mutational burden. He leads translational programs applying multi-modal liquid biopsy to guide radiation therapy decisions in locally advanced cancers.